Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology

Prakash Pispati  |  Issue: October 2012  |  October 1, 2012

For a standard question that nearly every patient has asked me—“Doctor, do I have rheumatism or arthritis? And what is the difference?”—it’s simple to explain, but with progress we have much more to offer. The word “rheumatism” in its broad sense is meant to convey musculoskeletal symptoms or a related disease. This ancient word is very much in use, even subdivided or in subsets, because rheumatism is meant to suggest soft-tissue rheumatism (i.e., a malady that affects structures outside the joint). Its other subsets over the years have seen names such as myositis, fasciitis, bursitis, tendonitis, tenosynovitis, fibrositis, fibromyositis, and the currently in-fashion fibromyalgia. Contemporary rheumatologists mockingly dismiss “soft-tissue rheumatism” as a waste paper–basket diagnosis. Will the rheumatologist of tomorrow do away with some of the current terms—who knows?

A glossary of rheumatic diseases is well recorded.1 Let’s look at a few examples. Some words seem to convey exactly what they are supposed to. For example, ankylosing spondylitis, just perfect; other examples: osteoarthritis, polymyalgia rheumatica, or, if you like, relapsing polychondritis. These terms sum up patients’ symptoms, even the disease. In short, easy to spell and pronounce, and comprehensible to doctors, patients, and healthcare professionals alike.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In contrast, we have systemic lupus erythematosus (SLE). Since the 16th century, the word “lupus” has been derived from a word for wolf, but then we added two words to describe systemic symptoms and rash. As a result, this three-word disease comprises 26 letters of the alphabet, is prone to mistaken spellings, is hard for patients to pronounce, and is, indeed, alarming. Isn’t it time we just used the five-letter, one-word “lupus” and discard the other two words? Diehard rheumatologists in their detailed case reports may certainly use the 26-letter, three-word designation if it pleases them, but let the world formally adopt the word “lupus.” It sounds patient friendly, even if the disease is not. No harm done.

Check out historical documents and you will come across “arthritis deformans” to describe what we understand today as “rheumatoid arthritis.” I believe that the term “arthritis deformans” is apt for this prototype disease. In 1858, Sir Alfred Baring Garrod from England probably thought otherwise, and so he coined “rheumatoid arthritis” (RA). It didn’t seem to carry much weight at that time, and Sir William Osler, in his “Principles and Practice of Medicine” (1909), continued to describe the disease arthritis deformans: “Once established, the disease is rarely curable. Too often it is a slow, but progressive, crippling of the joints, with a disability that makes the disease one of the most terrible of human afflictions.”2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsPractice SupportQuality Assurance/Improvement Tagged with:Antiphospholipid Antibody Syndrome (APS)Carpal Tunnel SyndromehistoricalHughes SyndromeJuvenile idiopathic arthritisPolymyalgia RheumaticaPractice ManagementReactive arthritisRheumatoid arthritisrheumatologistSclerodermaterminology

Related Articles

    Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions

    May 10, 2018

    NEW YORK (Reuters Health)—Patients with cutaneous lupus erythematosus (CLE) should be monitored closely for other autoimmune conditions, researchers suggest. Dr. Benjamin Chong, Dr. Linda Hynan and Elaine Kunzler of the University of Texas Southwestern Medical Center in Dallas analyzed data from 129 adults in the UTSW Cutaneous Lupus Registry (mean age, 49; 79% women). Individuals…

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Rheumatology Etymology

    August 1, 2011

    Defining some common words in the world of the rheumatologist

    Oksana Kuzmina/shutterstock.comx

    Environmental Factors in Pediatric Systemic Autoimmune Diseases

    March 20, 2017

    Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences